Lazard Downgrades Cardica (CRDC) to Hold
CRDC Hot Sheet
Rating Summary:2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Lazard Capital Markets downgrades Cardica (Nasdaq: CRDC) from Buy to Hold.
Shares of Cardica appear to be trading down on the downgrade this morning. The stock is currently down 5.7% to $2.74.
Click here to see all the analyst upgrades/downgrades on Cardica in real-time
Cardica, Inc. designs, manufactures, and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery.
Shares of Cardica appear to be trading down on the downgrade this morning. The stock is currently down 5.7% to $2.74.
Click here to see all the analyst upgrades/downgrades on Cardica in real-time
Cardica, Inc. designs, manufactures, and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
